DOCSLIB.ORG

Excel Partners, Upstate Venture Capital Report

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Excel Partners, Upstate Venture Capital Report Venture Capital and Seed Activity in NYS: Statistics for Upstate and Downstate 2005-2008 Part II of a Two-Part Series Judith J. Albers, Ph.D. Theresa B. Mazzullo Samir H. Navani Vivek Pandey May 2009 160 Linden Oaks, Suite E Rochester, New York 14625 www.excellny.com TABLEABLE OF OF CONTENTS CONTENTS I. Introduction ……………………………………………………………....………...3 II. Distribution of Capital…………………....……………………..…….…..………...3 III. Capital by Development Stage……………………………………………..……….7 IV. Deals ……………...…………...……………………………………………..…….10 V. Deal Size………………………………………………………………………..….11 VI. Sources of Capital………………………………………………………………….13 VII. Intellectual Capital…………………………………………………………………15 VIII. Investments by Industry………………………………………………………..…..16 IX. Entrepreneurial Ecosystem…………………..……………………………………. 17 X. Conclusions....……………………….…………………………………….……….19 APPENDIX………………………………………………………………………......20 Note: Unless otherwise referenced, all data in this report is from PriceWaterhouseCoopers / National Venture Capital Association (NVCA) MoneyTree report with data provided by Thompson Financial (www.pwcmoneytree.com). © 2009 Excell Partners Inc 2 I. Introduction This paper is the second part of a two part series. The first paper entitled Venture Capital and Seed Activity in NYS: Perception, Reality and Unrealized Potential told the story about venture capital activity, particularly at the seed stage, and the unrealized potential in leveraging the incredible amount of Research and Development (R&D) that is being generated at pre-eminent universities across the region. There are many misperceptions and misunderstandings about these matters among our state, regional, and local community stakeholders. Data from many different sources was knit together to paint the picture of what is really happening in New York State (NYS). We also offered suggestions related to instituting a State-Supported Seed Fund for NY modeled after the Ben Franklin Technology Partners (BFTP) in Pennsylvania. In this sequel report, we again address the important issue of venture capital (VC) investing in NYS. However, here we take a deep dive into one primary data source, i.e., the raw data on www.pwcmoneytree.com for both the Upstate and Downstate regions. We have created a data base for every venture deal reported to the National Venture Capital Association (NVCA) for a four-year period from January 2005 through and including December 2008 (2005-2008). We take a close look at the distribution of capital among the metro regions from Buffalo to Long Island and how capital is invested by development stage. Data on the number of deals by development stage paints a picture of the level of VC activity in each region. In the venture world, “right-sizing” deals is an important consideration, particularly at the earliest stages of a company’s development. We consider the size of the deals by development stage by region. Because VCs, Angels, and State-Supported Seed Funds all participate to different degrees at the seed stage, we explore what constitutes a “real seed deal”. The next question then becomes, where are the NYS investment dollars coming from, i.e., sources of capital. It appears that less than expected is coming from NYS VCs. Because of this, the NYS Comptroller’s Office has committed to providing Common Retirement Funds (CRF) to VC firms for in-state investing. We’ll say a few words about the impact of the CRF monies. We’ll also explore some strange juxtapositions. In Upstate and Long Island there is an enormous amount of intellectual capital but a dearth of venture capital. In NYC, there is an enormous amount of intellectual capital in the life sciences, but the lion’s share of VC monies is invested in the “soft sciences” and services. We attribute these paradoxes to the lack of an entrepreneurial ecosystem both Upstate and Downstate for translating academic R&D into investable companies. We conclude by identifying the major missing components of the ecosystem and suggesting gap filling measures. II. Distribution of Capital Capital Invested Nationwide. Our paradigm in this paper will be to consistently present our state data in the larger context of what’s happening nationally. So, we’ll start “big picture” and ask the most fundamental question related to venture capital: how much is being invested? © 2009 Excell Partners Inc 3 Figure 1 shows that the venture market has been fairly stable during 2005-2008 and national investing levels have been in the range of $23 - $31B. The impact of the current economic crisis is already evident in the 2008 “dip” and recent reports are showing a continued decrease in VC activity for 2009. Figure 1: Annual National VC Investment The next question then becomes: So, where is the money going? Figure 2 below shows cumulative numbers for the time period of interest and calculates a percentage for each region. So, with data aggregated over four years, at the top of the list we have (no surprise) Silicon Valley. Note that, in addition, LA/Orange County and San Diego totals (along with a small amount from Sacramento/N. Cal) combine to give California 48.5% of the venture capital in the nation. New England (which is basically Boston) comes in second place at about 12%. “NY Metro” has a respectable rank of #3 on the list. 2005-2008 2005-2008 Region Cumulative Amount % of Total Cumulative Invested ($M) Number of Deals Silicon Valley $39,942 36.4% 4590 New England $13,160 12.0% 1814 NY Metro $7,596 6.9% 1023 LA/Orange County $7,188 6.6% 848 Southeast $5,625 5.1% 870 San Diego $5,504 5.0% 547 Texas $5,318 4.9% 674 DC/Metroplex $4,487 4.1% 815 Midwest $4,328 3.9% 879 Philadelphia Metro $2,908 2.7% 454 Colorado $2,711 2.5% 371 SouthWest $2,078 1.9% 333 Northwest $5,154 4.7% 767 North Central $1,976 1.8% 292 Sacramento/N.Cal $530 0.5% 78 Upstate NY $429 0.4% 125 AK/HI/PR $403 0.4% 113 South Central $283 0.3% 100 TOTAL $109,620 100.0% 14693 Figure 2: National VC Investments, Cumulative 2005-2008 However, there are two matters to note here. First, there is a big chasm between the more than 36% that Silicon Valley draws in venture capital versus the less than 7% for NY Metro. But even more © 2009 Excell Partners Inc 4 important is the fact that pwcmoneytree.com defines NY Metro as “the Metropolitan NY area, northern New Jersey (NJ), and Fairfield County, Connecticut (CT)”, the tri-state region. So, before we can continue, we need to make sure we really understand how much of NY Metro capital is actually staying in-state versus how much is headed to NJ and CT. Distribution of Capital in “Metro NY”. The pie chart below is illuminating. 41% of the total NY Metro venture capital technically goes out of state while 59% remains in NYC and Long Island, i.e., Downstate NY. Long Island, $111M, 1% Connecticut $782M Cumulative for 10% 2005-2008: $7,596 M New Jersey $2,306M NYC 31% $4,343M 58% Figure 3: Distribution of Capital for “Metro NY” But this paper is about NYS. It is Upstate and Downstate NY that are governed by the same legislative body in Albany and that contribute to the NYS economy. So, for our purposes moving forward, all data for NJ and CT will be deleted and, while they are disparate regions, we will “lump together” Upstate and Downstate NY. In fact, that’s what we did next. Capital Invested in NYS. We combined the Upstate and Downstate totals to see what the bar graph would look like for 2005-2008 just for NYS. Fairly consistent with the national numbers, we see a picture of a fairly stable market, averaging about $1.2B annually. (Although it is interesting that NYS totals for 2008 did not “dip”.) $1,307M $1,303M $1,400 Cumulative for $1,127M $1,156M 2005-2008: $1,200 $4,893 M $1,000 $800 Downstate NY $600 Millions Upstate NY $400 $200 $ 2005 2006 2007 2008 Figure 4: Annual NYS VC Investment © 2009 Excell Partners Inc 5 By eliminating NJ and CT data from NY Metro and combining what was left with the Upstate numbers, NYS ends up representing 4.5% of the national total for that time period. If we were to reconfigure Figure 2 and define NYS as a “region”, it would be #7 on the list. The chasm between NY and Silicon Valley widens. And now there is a big difference between NY and the Boston area. 2005-2008 Region % of Total Investment ($M) Silicon Valley $39,942 36.4% New England $13,160 12.0% LA/Orange County $7,188 6.6% Southeast $5,625 5.1% San Diego $5,504 5.0% Texas $5,318 4.9% New York State $4,893 4.5% TOTAL $109,620 100.0% Figure 5: If NYS were Recognized by PWC as a “Region” Distribution of Capital in NYS. Now that we’re confident that we’re looking just at NYS numbers, we will again assessSum the ofdistribution financing of capital, amount this time - In just Millions for the state. Long Island Albany 2.3% Ithaca North NYC Upstate Region 89% 9.0% Buffalo Other Syracuse Rochester Figure 6: Distribution of Capital, NYS 2005-2008 As shown above in the left pie, NYC receives 89% of the venture capital in NYS. Long Island receives about 2% and all of Upstate is at 9%. In the “pie of pie” chart to the right, we magnify the Upstate region to determine where in Upstate the money goes. Buffalo and Rochester each receive about a quarter of the Upstate capital. (Keep in mind that this is a quarter of Upstate’s 9% share of NYS, so overall only 2% of the state’s total.) Ithaca is a small town which ranks with the major metro regions and is on par with Albany.
Load more

Recommended publications
  • Philadelphia Investment Trends Report
    Venture impact Technology investment in the Greater Philadelphia region Trends and highlights, January 2008 to June 2013 Innovation, investment and opportunity On behalf of EY, Ben Franklin Technology Partners of Southeastern Pennsylvania and the Greater Philadelphia Alliance for Capital and Technologies (PACT), we are pleased to present this review 421 companies of technology investment trends and highlights in the Greater Philadelphia region. $4.1 billion The technology investment community in the Greater Philadelphia region includes a wide variety of funding sources supporting a diverse array of companies and industry sectors. In this report, Total investment since we’ve analyzed more than a thousand investment rounds and January 2008 exits that occurred in the Philadelphia region since 2008 – including investments from venture capital fi rms (VCs), angel investors (Angels), corporate/strategic investors, seed funds, accelerators and other sources of funding. As shown in this report, 2012 reversed a post-recession slowdown in venture funding in Greater Philadelphia, and to date, 2013 has brought a welcome increase in the amount of new funds available at regional investment fi rms. These are positive signs for our region’s technology companies, as are the increasing number of exits via IPO and acquisition, which serve as further validation of the investment opportunities created by our region’s growing technology sector. We encourage you to explore this report, and we hope that it will provide useful insights into the current state of
    [Show full text]
  • Overview of Cleveland's Health Care Industry and Bioenterprise Initiative
    Overview of Cleveland’s Health Care Industry and BioEnterprise Initiative November 14, 2007 1 Overview • Regional Health Care Base: 2002 • Transformation: Role of State • BioEnterprise and Entrepreneurship • Lessons Learned 2 Cleveland Health Care Base Nationally-recognized leaders in clinical care and research … • > $450 Million in annual research • Numerous nationally-distinctive programs including: • Cardiovascular • Cancer • Neurology • Orthopedics • Surgery • Pediatrics • Medical imaging • Biomedical engineering • Stem cells & tissue engineering • Advanced materials • Molecular diagnostics • Anti-infectives • Prions • Destination for innovation and care 3 Cleveland Health Care Base … a broad industry base… • ~500 health care Biopharma- companies in region ceutical 16% • Five >$1 billion companies Device/ or divisions Equipment Other 68% • Over 20,000 employees 6% Health Care Services/IT 10% 4 Weak Commercialization …However, few companies were attracting growth equity CLEVELAND AREA CLEVELAND AREA HEALTH CARE VENTURE INVESTMENT HEALTH CARE VENTURE INVESTMENT $ Millions Companies Financed 6 33 5 8 2 01 02 0 0 0 001 2 2 2 20 5 Source: Dow Jones Venture Wire; Venture Source; BioEnterprise Broad Effort Required • Community- People wide effort Pipeline • Collaboration Growth Clinical • Connectedness … regionally Capital and nationally 6 2002: Commitment to Growth • Private • Renewed focus on entrepreneurs and innovation • Technology transfer culture capabilities significantly enhanced • Investment firms and professional services • Public
    [Show full text]
  • Clarity on Mergers and Acquisitions
    Clarity on Mergers & Acquisitions Swiss deal flows hit record high January 2019 16 2018 activity and 2019 outlook An industry-by-industry look at last year’s deals and what you might expect over the next 12 months. 22 Private Equity and the Swiss economy SECA’s General Secretary shares his insights into how Private Equity makes the Swiss economy stronger. 76 Detailed 2018 transaction list View the M&A deals that involved a Swiss buyer, seller or target. 28 4 12 6 18 10 Clarity on Mergers & Acquisitions CONTENT Clarity on Mergers & Acquisitions EDITORIAL CHAPTER II 3 Switzerland’s M&A activity 34 Industry Sector Pages sets a new record 36 Chemicals 40 Commodities CHAPTER I 44 Consumer Markets Overview 48 Financial Services 52 Industrial Markets 12 Media headlines 56 Pharmaceuticals & Life Sciences 60 Power & Utilities 14 Summary 64 Private Equity 68 Real Estate 72 Technology, Media & Telecommunications Focus Topic: Private Equity CHAPTER III 22 What is it and how does it work? 76 List of Swiss M&A 26 The changing legal and regulatory framework for Private Equity in Switzerland transactions in 2018 30 Interview with Maurice Pedergnana, SECA: CHAPTER IV The national economy is healthier thanks to private equity 110 Tombstones 116 PINBOARD 117 CONTACT & IMPRINT 1 2 Clarity on Mergers & Acquisitions EDITORIAL Switzerland’s M&A activity sets a new record activity. In fact, acquisitions by Private Equity houses once more exceeded exits, in a further sign of the growing importance of this community on the M&A landscape. A considerable amount of the M&A activity observed last year is due to changing consumer behaviors and rapid advances in technology – not least i4.0, the ’fourth industrial revolution’ that is upon us thanks to developments in artificial intelligence.
    [Show full text]
  • HEALTHCARE INDUSTRY ASSOCIATION (HCIA) RESUME BOOK Columbia Healthcare and Pharmaceutical Management Program
    HEALTHCARE INDUSTRY ASSOCIATION (HCIA) RESUME BOOK Columbia Healthcare and Pharmaceutical Management Program CLASS OF 2017 CLASS OF 2018 CONTENTS 2017 RESUMES 11 ROBERT MORIN 20 SONYA NANDA JT MUNCH JAY NICHOLAS 3 LISA AULT RICHARD MURPHEY LIZ NYLUND JULIE BAILEY BORMAN ELISA 12 SAM NELSON 21 PATIENCE OLANITORI ADAM NORRIS MILICA PAVLOVIC 4 WILLIAM CAMPBELL COURTNEY PITTENGER ALLISON PERRIN GUIDO CASTAGNOLA CECE CHEN 13 VARNA RAMAN 22 PRAMOD PRASAD MORGAN SHATTUCK DARPITA PUROHIT 5 JAMES CHEUNG STEPH SHAW FENG QIAN BIRCE CIRAVOGLU EVAN COHEN 14 XIN (TONY) SHU 23 DIVYA RAJ ALEXANDER APARNA RAMAKRISHNAN 6 ELIZABETH COLONNA VON FALENHAUSEN ISOBEL ROSENTHAL CHRISTIAN DUNNE PHILONG DUONG 24 MEREDITH SHIELDS 2018 RESUMES JASON ZE SU 7 LEV ELDEMIR KEITH TABIN PAWEL FEDEJKO 14 YAPRAK BARAN 25 JEFFERSON TAYLOR EMILY GARVIN 15 JAMES BEALL ANGELA WANG DIANA BERKOVITS 8 RACHEL HAN MALLORY WEST CAROLYN HEISLER TRAVIS BOWDEN 26 ELLEN YANG QIAN HU 16 JESSICA CHO THORSON ZACH 9 SCOTT JOHNSON JOSEPH COSENTINO HILLARY KAPLAN KATIE DEAN VICTORIA LAI 17 ADAM ESCALANTE 10 SHREYAS LAKSHMINARAYAN MATTHEW FOXMAN JOSEPHINE LINTHORST ANDREW GOTTESDIENER JAMIE MEYERSON 18 STEPHANIE HU NAMWON JUNG JESSICA KIM 19 CHASE KNIGHT MOLLY MAGNUSON ALEX MARGOLIS HCIA AT COLUMBIA BUSINESS SCHOOL The Healthcare Industry Association (HCIA) is committed to expanding opportunities outside of the classroom for Columbia Business School students to learn about the many segments of the healthcare industry. Working in close collaboration with the Healthcare and Pharmaceutical Management Program, HCIA organizes a variety of activities throughout the year. It offers members the opportunity to increase their knowledge of the healthcare industry, expand their professional networks, learn about diverse career paths, and secure internships, full-time opportunities, and in-semester projects.
    [Show full text]
  • UHF's 2016 Annual Report
    UNITED HOSPITAL FUND Building a more effective health care system for every New Yorker ANNUAL REPORT 2016 OFFICERS AND DIRECTORS Officers Directors Improving Health Care for Every New Yorker J. Barclay Collins II Michelle A. Adams United Hospital Fund works to build a more effective health care Chairman Bettina Alonso system for every New Yorker. An independent, nonprofit Stephen Berger organization, we analyze public policy to inform decision-makers, James R. Tallon, Jr. Lori Evans Bernstein find common ground among diverse stakeholders, and develop and President Jo Ivey Boufford, MD support innovative programs that improve the quality, accessibility, Rev. John E. Carrington John C. Simons Dale C. Christensen, Jr. affordability, and experience of patient care. Frederick W. Telling, PhD J. Barclay Collins II Vice Chairmen Michael R. Golding, MD Eugene Keilin Sheila M. Abrams Cary A. Kravet United Hospital Fund Annual Report Treasurer Josh N. Kuriloff Fiscal Year 2015–2016 David Levy, MD Sheila M. Abrams Howard P. Milstein 2 From the President Sally J. Rogers Susana R. Morales, MD 4 Programs Senior Vice Presidents Robert C. Osborne John C. Simons 11 Grantmaking Deborah E. Halper Michael A. Stocker, MD, MPH 13 Financial Report Chad Shearer James R. Tallon, Jr. 16 Contributors Vice Presidents Frederick W. Telling, PhD Mary Beth C. Tully 20 Staff Amanda A. Williams Corporate Secretary Honorary Directors John K. Castle Timothy C. Forbes Barbara P. Gimbel Mary H. Schachne Allan Weissglass FROM THE CHAIRMAN “Working to build a more effective health care system for every New Yorker.” J. BARCLAY COLLINS II It would be hard to get more explicit or more concise than this CHAIRMAN UNITED HOSPITAL FUND reformulation of United Hospital Fund’s mission statement, which we undertook this year to better reflect UHF’s role in our rapidly transforming health care system.
    [Show full text]
  • Opioid Addiction
    Opioid Addiction Industry Outlook and Investment Opportunities 7 February 2021 1 Introduction Opioid addiction is a national epidemic with dangerous consequences, and without intervention, it will remain so for decades to come. The increase in opioid use, addiction and related deaths poses a critical challenge to society, as it affects all ages and demographic groups in the U.S. Private capital can play a significant role in combating the opioid crisis. Funding the development of new interventions, alternative drug therapies and innovative technologies can reduce widespread dependence and suffering. Within these distinct approaches lie many opportunities for investors to advance solutions capable of delivering affected individuals from despair and matching the desired risk-return profile. Highlights About 2 million people have been diagnosed with opioid use disorder (OUD) in the U.S. An additional 4 to 6 million people may also have the disease but have not been formally diagnosed. • According to the National Institute for Drug Abuse (NIDA), more than 130 Americans die every day from overdoses. • This translates into an annual cost of more than $78.5 billion in the U.S. across factors like systemic healthcare costs, lost productivity, treatment, and criminal justice activity. In one study, 35% of patients who were prescribed an opioid had a known risk factor for opioid use disorder (e.g. another substance abuse disorder). • Alerting healthcare providers about patients’ risk factors can allow doctors to make informed decisions when determining if patients should receive opioids or an alternative medication. • Significant progress can be achieved by improving how high-risk patients are handled and averting new opioid use disorder cases proactively.
    [Show full text]
  • CI Encourages You to Share This Content, However, in Doing So, You May Not Alter Its Contents
    Copyright © 2013 Connecticut Innovations All Rights Reserved CI encourages you to share this content, however, in doing so, you may not alter its contents. ctinnovations.com 1 FINDING THE RIGHT VC FOR YOUR COMPANY Tips from Successful Entrepreneurs Transforming a great idea into a successful company takes money. If you’re an entrepreneur, chances are that the first funds you’ll cobble together will come from you, your family, your friends and perhaps an angel investor. But at some point, taking your startup company to the next, crucial, level is likely to require an infusion of funds only a venture capital resource can provide. How do you go about finding the right VC for your particular company? Connecticut Innovations asked four experienced entrepreneurs with successful fundraising track records to offer their advice. Here are the pointers they offered: Start with Smart Targeting “Every firm has a sweet spot they’re looking for in terms of their favorite kinds of deals,” says Harry Penner Jr., executive chairman and co- founder of New Haven Pharmaceuticals. “You can save yourself from kissing a lot of frogs that turn out not to be princes if you do some homework before you start knocking on doors.” Do your research. Christopher McLeod, president and CEO of AxioMx Inc., suggests exploring which VCs have invested in other companies in your industry. Check out VCs’ portfolios online to see if they’ve invested in companies similar to yours. And make sure they’re actually working on deals in your time frame, says Bryant Guffey, CEO of ZetrOZ Inc.
    [Show full text]
  • Realim O Investm Ent© 2008
    REALIMO INVESTMENT vous permet d’entrer en relation avec les fonds français : 123 VENTURE - 17CAPITAL - 21 CENTRALE PARTNERS - 360° CAPITAL PARTNERS - 3I - 4D GLOBAL ENERGY ADVISORS - A PLUS FINANCE - ABENEX CAPITAL - ACCESS CAPITAL PARTNERS - ACE MANAGEMENT - ACG PRIVATE EQUITY - ACOFI GESTION - ACTEM PARTNERS - ACTIVA CAPITAL - ADC (ALLIANCE DEVELOPPEMENT CONSEIL) - ADVENT INTERNATIONAL - AGF PRIVATE EQUITY - AGREGATOR - AGRO INVEST SAS - ALLIANCE ENTREPRENDRE - ALOE PRIVATE EQUITY SAS - ALP CAPITAL - ALTER CAPITAL PARTNERS - ALTO INVEST - ALVEN CAPITAL PARTNERS - AMS INDUSTRIES - ANTIN INFRASTRUCTURE PARTNERS - APAX PARTNERS MIDMARKET - APAX PARTNERS SA - APOLLO MANAGEMENT INTERNATIONAL LLP - AQUASOURCA - ARCIS FINANCE - ARDENS ET ASSOCIES - ARGOS SODITIC FRANCE - ASSYA CAPITAL - ASTORG PARTNERS ATRIA CAPITAL PARTENAIRES - AURIGA PARTNERS - AURINVEST PARTENAIRES - AUXITEX - AVENIR ENTREPRISES - AVENIR FINANCE GESTION - AXA PRIVATE EQUITY - AZULIS CAPITAL - BAC PARTENAIRES GESTION - BANEXI VENTURES PARTNERS - BARCLAYS PRIVATE EQUITY FRANCE - BC PARTNERS - BIOAM GESTION - BLACKFIN CAPITAL PARTNERS BNP PARIBAS DEVELOPPEMENT - BNP PARIBAS PRIVATE EQUITY SAS - BRIDGEPOINT - BTP CAPITAL INVESTISSEMENT - BURELLE PARTICIPATIONS BUTLER CAPITAL PARTNERS - CAAM CI - CAP DECISIF MANAGEMENT - CAPZANINE - CARVEST - CATHAY CAPITAL PE - CAVIPAR - CDC CAPITAL INVESTISSEMENT - CDC ENTREPRISES - CDC INNOVATION - CEA VALORISATION - CENTRE CAPITAL DEVELOPPEMENT - CEREA GESTION - CHARTERHOUSE SERVICES FRANCE - CHEQUERS CAPITAL - CIC BANQUE DE VIZILLE -
    [Show full text]
  • REPORT 2015 Vol. 6
    REPORT 2015 vol. 6 Forward-thinking articles from our global network of innovation ecosystem experts KFR Staff KF Board of Directors Publisher Brian Dovey, Chairman Kauffman Fellows Press Domain Associates Executive Editor Tom Baruch Phil Wickham Formation 8 Managing Editor Jason Green Anna F.Doherty Emergence Capital Partners Associate Editor Karen Kerr Leslie F. Peters Agile Equities, LLC Production and Design Audrey MacLean Anna F. Doherty Stanford University Leslie F. Peters Susan Mason Printer Aligned Partners Almaden Press www.almadenpress.com Jenny Rooke Copyright Fidelity Biosciences © 2015 Kauffman Fellows. All rights reserved. Christian Weddell Under no circumstances shall any of the information provided herein be construed as investment advice of any kind. Copan About the Editor Phil Wickham Anna F. Doherty is an accomplished editor and writing Kauffman Fellows coach with a unique collaborative focus in her work. She has 20 years of editing experience on three continents in a variety of business industries. Through her firm, Together Editing & Design, she has offered a full suite of writing, design, and publishing services to Kauffman Fellows since 2009. Leslie F. Peters is the Lead Designer on the TE&D team. www.togetherediting.com www.kauffmanfellows.org Town & Country Village • 855 El Camino Real, Suite 12 • Palo Alto, CA 94301 Phone: 650-561-7450 • Fax: 650-561-7451 Venturing into the Industry: Lessons Learned from a VCpreneur Ahmad Takatkah Class 17 My life has been swinging between in Empretec,2 an international entrepreneurship and venture capital for more entrepreneurship training program than ten years now. In each cycle, I get closer that is managed by the United Nations and to my goal, even as I refine my goals further.
    [Show full text]
  • REPORT 2015 Vol. 6
    REPORT 2015 vol. 6 Forward-thinking articles from our global network of innovation ecosystem experts KFR Staff KF Board of Directors Publisher Brian Dovey, Chairman Kauffman Fellows Press Domain Associates Executive Editor Tom Baruch Phil Wickham Formation 8 Managing Editor Jason Green Anna F.Doherty Emergence Capital Partners Associate Editor Karen Kerr Leslie F. Peters Agile Equities, LLC Production and Design Audrey MacLean Anna F. Doherty Stanford University Leslie F. Peters Susan Mason Printer Aligned Partners Almaden Press www.almadenpress.com Jenny Rooke Copyright Fidelity Biosciences © 2015 Kauffman Fellows. All rights reserved. Christian Weddell Under no circumstances shall any of the information provided herein be construed as investment advice of any kind. Copan About the Editor Phil Wickham Anna F. Doherty is an accomplished editor and writing Kauffman Fellows coach with a unique collaborative focus in her work. She has 20 years of editing experience on three continents in a variety of business industries. Through her firm, Together Editing & Design, she has offered a full suite of writing, design, and publishing services to Kauffman Fellows since 2009. Leslie F. Peters is the Lead Designer on the TE&D team. www.togetherediting.com www.kauffmanfellows.org Town & Country Village • 855 El Camino Real, Suite 12 • Palo Alto, CA 94301 Phone: 650-561-7450 • Fax: 650-561-7451 A Hybrid Venture Capital Model for the Middle East Tarek Sadi Class 17 Youth unemployment in MENA, 1. Ten active family offices in the Middle East. 2. Five entrepreneurs who have raised capital in according to the Skoll Foundation, the region and beyond. is around 26% and among certain 3.
    [Show full text]
  • 3 Rivers Venture Fair Invite
    JOIN US FOR ONE OF THE COUNTRY’S FOREMOST TECHNOLOGY INVESTMENT SHOWCASES A catalyst for over $400 million in investment capital since 2002 Featuring Keynote Speaker Josh Linkner Founder, Chairman & Former CEO of ePrize CEO & Managing Partner of Detroit Venture Partners Best-Selling Author April 10 & 11, 2013 PNC Park | Pittsburgh, PA Proudly Presented by the Pittsburgh Venture Capital Association in partnership with leading organizations throughout the Midwest, Mid-Atlantic and Northeast Regions ABOUT THE 3 Rivers Venture Fair Since its debut in 2002, the 3 Rivers Venture Fair (3RVF) has become a recognized proving ground for promising technology pioneers, helping featured innovators raise more than $400 million in capital. Please join more than 600 attendees as they discover groundbreaking investment opportunities and explore over 40 remarkable advancements in life sciences, energy, communications, manufacturing, media and more. In addition to investor selected opportunities, the 3RVF also features networking, exhibits, a university technology showcase luncheon and awards, and investment-related panel discussions. WHAT’S NEW IN 2013? Two Concurrent Presentation Tracks More Companies. More Opportunities! . Choice of Two Breakfast Panels for Both Early & Later Stage Ventures Early Stage Sources of Capital: A look at economic development opportunities, crowdfunding & angel investors Funding Opportunities & Exits for Later Stage Companies: Exploring corporate M&A, business development, private equity & partnerships WHO Schedule SHOULD (subject to change) ATTEND WEDNESDAY, APRIL 10th 1:00 to 7:30 pm VENTURE Registration & Exhibits CAPITALISTS . 1:00 to 5:00 pm PRIVATE INVESTORS “Shark Tank” University . Technology Showcase & Luncheon LENDERS . 5:00 to 7:30 pm INVESTMENT Opening Cocktail Reception BANKERS & BROKERS .
    [Show full text]
  • Meet the Busiest Developer in the City
    20100405-NEWS--0001-NAT-CCI-CN_-- 4/2/2010 8:31 PM Page 1 INSIDE Financial reform’s TOP STORIES delicate task —Kathryn Bra manufacturer Wylde of the Maidenform needs Partnership for New no extra padding ® York City PAGE 2 Page 11 redux Macy’s parade VOL. XXVI, NO. 14 WWW.CRAINSNEWYORK.COM APRIL 5-11, 2010 PRICE: $3.00 route: It’s still up in Meet the the air busiest PAGE 2 Restaurants offer developer job security? Who knew? in the city PAGE 3 Web sites ramp up Gary Barnett has little fight for women debt, pots of cash and PAGE 3 a fair share of secrets Two dance troupes BY THERESA AGOVINO learn a new step: visitors can tour Gary Barnett’s real merging companies estate empire without ever leaving his PAGE 4 midtown office. A model of his nearly completed condo, 535 West End Avenue, sits just inside the door. Across the room is a mock-up of a hefty slice of the Upper BUSINESS LIVES West Side that includes the two towers he’s already built there, the two under construction and the five he hopes to start in the future.Nearby are models of the hotel/condo he’s putting up on West 57th Street and the 34-story tow- er going up in the diamond district. At a time when the credit crunch and recession have pushed many expe- rienced developers to the sidelines and inexperienced ones to the poorhouse, the ability of Extell Development Co.’s GOTHAM GIGS See BUSIEST on Page 21 Spring in bloom at the makeup counter P.
    [Show full text]